INO:NASDAQ
Inovio Pharmaceuticals Inc
$1.07
arrow_downward
-7.76%(-0.090) 1D
$1.09
arrow_upward
+1.87% (+0.020)bedtimeAfter hours
Closed: Jun 5, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
$1.17
High
$1.17
Low
$1.06
Mkt. cap
88.03M
Avg. vol.
3.17M
Volume
3.32M
52-wk high
$2.98
52-wk low
$1.03
EPS
-$1.70
Beta
1.49
Shares outstanding
82.27M
No. of employees
112
Open
$1.17
High
$1.17
Low
$1.06
Mkt. cap
88.03M
Avg. vol.
3.17M
Volume
3.32M
52-wk high
$2.98
52-wk low
$1.03
EPS
-$1.70
Beta
1.49
Shares outstanding
82.27M
No. of employees
112
Analyst outlook
Analyst Ratings
Based on 2 analysts giving stock ratings to INO in the past 3 months
Buy
Buy
1
Hold
1
Sell
0
12 month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INO in the last 3 months.
Highest
Current $1.07
$6.00 (+460.75%)
Average
$4.25 (+297.20%)
Lowest
$2.50 (+133.64%)
News stories
From sources across the web
Simply Wall Street
·
47 minutes ago
Astera Labs’ Taiwan Lab Expansion Deepens AI Ecosystem Ties – What Does It Mean For ALAB?
Simply Wall Street
·
47 minutes ago
SoFi Class Action Puts Reporting Practices And Valuation Premium In Focus
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc
AI content may include mistakes. Learn more